NCT00983320

Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Université de Sherbrooke · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This is a double-blind, randomized, placebo-controlled trial measuring the impact of quetiapine on clinical and experimental measures of pain in fibromyalgia and its biochemical correlates.

Detailed description

This is a double-blind, randomized, placebo-controlled trial measuring the impact of quetiapine on clinical and experimental measures of pain in fibromyalgia. The study also seeks to measure the hormonal, immunological and neurochemical correlates of clinical changes in time.

Conditions

• Fibromyalgia

Interventions

Type	Name	Description
DRUG	quetiapine	flexible dosage (50 to 300 mg)
DRUG	placebo	placebo

Timeline

• Start date: 2008-04-01
• Primary completion: 2011-10-01
• Completion: 2011-10-01
• First posted: 2009-09-24
• Last updated: 2011-10-05

Locations

1 site across 1 country: Canada